MAPT and Alzheimer disease: The mRNA expression of TCA cycle genes in AD patients was systematically revealed by brain and peripheral blood cells transcriptome data, and combined with MMSE, Aβ/Tau correlation analysis to confirm that SUCLA2, MDH1, and PDHB genes may be candidate biomarkers that can effectively track the pathological and clinical manifestations of AD patients (Figure 5A).